Examining the Medtech M&A Boom: Global Forces Operating on the Sector

Nov 2018

Livingstone has curated a panel of CEOs, OEMS and private equity investors to discuss key drivers of the medtech M&A boom.

We’ll explore why medtech assets are trading at premium prices, discuss how consolidation in the global medtech industry is impacting companies throughout the supply chain and ask what the future holds for medtech industry participants.

Karl Freimuth, partner and co-head of the US industrials practice at Livingstone will moderate the discussion at mHUB Chicago on Thursday, November 15, 2018.

Learn more and register here.


OUR PANELISTS:

 

 

Kevin Cordero
Director, Clinical Research & Market Intelligence
Stryker Craniomaxillofacial

Hunter Craig
Vice President
GTCR

Steve Sundberg
CEO
MedTorque

Chris Witham
CEO
Motion Dynamics

 

 

 

Facebooktwitterlinkedinmail